1-9 of 9
Gareth L. Bond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response

Available to Purchase
Ping Zhang, Isaac Kitchen-Smith, Lingyun Xiong, Giovanni Stracquadanio, Katherine Brown, Philipp H. Richter, Marsha D. Wallace, Elisabeth Bond, Natasha Sahgal, Samantha Moore, Svanhild Nornes, Sarah De Val, Mirvat Surakhy, David Sims, Xuting Wang, Douglas A. Bell, Jorge Zeron-Medina, Yanyan Jiang, Anderson J. Ryan, Joanna L. Selfe, Janet Shipley, Siddhartha Kar, Paul D. Pharoah, Chey Loveday, Rick Jansen, Lukasz F. Grochola, Claire Palles, Andrew Protheroe, Val Millar, Daniel V. Ebner, Meghana Pagadala, Sarah P. Blagden, Timothy S. Maughan, Enric Domingo, Ian Tomlinson, Clare Turnbull, Hannah Carter, Gareth L. Bond
Journal: Cancer Research
Cancer Res (2021) 81 (7): 1667–1680.
https://doi.org/10.1158/0008-5472.CAN-20-0177
Published: 01 April 2021
View articletitled, Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response
Open the PDF for Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response in another window
Includes: Supplementary data
Journal Articles

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Free
Bernard Leroy, Mandy L. Ballinger, Fanny Baran-Marszak, Gareth L. Bond, Antony Braithwaite, Nicole Concin, Lawrence A. Donehower, Wafik S. El-Deiry, Pierre Fenaux, Gianluca Gaidano, Anita Langerød, Eva Hellstrom-Lindberg, Richard Iggo, Jacqueline Lehmann-Che, Phuong L. Mai, David Malkin, Ute M. Moll, Jeffrey N. Myers, Kim E. Nichols, Sarka Pospisilova, Patricia Ashton-Prolla, Davide Rossi, Sharon A. Savage, Louise C. Strong, Patricia N. Tonin, Robert Zeillinger, Thorsten Zenz, Joseph F. Fraumeni, Jr, Peter E.M. Taschner, Pierre Hainaut, Thierry Soussi
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (6): 1250–1260.
https://doi.org/10.1158/0008-5472.CAN-16-2179
Published: 14 March 2017
View articletitled, Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
Open the PDF for Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice in another window
Includes: Supplementary data
Journal Articles

Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients

Free
Christine G. Stoehr, Robert Stoehr, Antonia Wenners, Arndt Hartmann, Simone Bertz, Verena Spath, Bernhard Walter, Kerstin Junker, Holger Moch, Raoul Hintze, Stefan Denzinger, Elisabeth E. Bond, Gareth L. Bond, Karen Bluemke, Katrin Weigelt, Verena Lieb, Elke Nolte, Paolo Fornara, Bernd Wullich, Sven Wach, Helge W. Taubert
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3700.
https://doi.org/10.1158/1538-7445.AM2016-3700
Published: 15 July 2016
View articletitled, Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients
Journal Articles

Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer

Free
Anna M. Grawenda, Elen K. Møller, Suzanne Lam, Emmanouela Repapi, Amina F.A.S. Teunisse, Grethe I.G. Alnæs, Anne-Lise Børresen-Dale, Vessela N. Kristensen, Colin R. Goding, Aart G. Jochemsen, Hege Edvardsen, Gareth L. Bond
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (4): 698–708.
https://doi.org/10.1158/0008-5472.CAN-14-2637
Published: 15 February 2015
View articletitled, Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer
Open the PDF for Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer in another window
Journal Articles

Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer

Free
Kristiaan Lenos, Anna M. Grawenda, Kirsten Lodder, Marieke L. Kuijjer, Amina F.A.S. Teunisse, Emmanouela Repapi, Lukasz F. Grochola, Frank Bartel, Pancras C.W. Hogendoorn, Peter Wuerl, Helge Taubert, Anne-Marie Cleton-Jansen, Gareth L. Bond, Aart G. Jochemsen
Journal: Cancer Research
Cancer Res (2012) 72 (16): 4074–4084.
https://doi.org/10.1158/0008-5472.CAN-12-0215
Published: 14 August 2012
View articletitled, Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Open the PDF for Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer in another window
Includes: Supplementary data
Journal Articles

A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma

Free
Karen S. Yee, Lukasz Grochola, Garth Hamilton, Anna Grawenda, Elisabeth E. Bond, Helge Taubert, Peter Wurl, Gareth L. Bond, Eric O'Neill
Journal: Cancer Research
Cancer Res (2012) 72 (9): 2206–2217.
https://doi.org/10.1158/0008-5472.CAN-11-2906
Published: 30 April 2012
View articletitled, A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
Open the PDF for A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma in another window
Includes: Supplementary data
Journal Articles

Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3τ and CD44 That Affect Sarcoma Incidence and Survival

Free
Alexei Vazquez, Lukasz F. Grochola, Elisabeth E. Bond, Arnold J. Levine, Helge Taubert, Thomas H. Müller, Peter Würl, Gareth L. Bond
Journal: Cancer Research
Cancer Res (2010) 70 (1): 172–180.
https://doi.org/10.1158/0008-5472.CAN-09-2218
Published: 04 January 2010
View articletitled, Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3τ and CD44 That Affect Sarcoma Incidence and Survival
Open the PDF for Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3τ and CD44 That Affect Sarcoma Incidence and Survival in another window
Includes: Supplementary data
Journal Articles

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

Free
Gareth L. Bond, Kim M. Hirshfield, Tomas Kirchhoff, Gabriella Alexe, Elisabeth E. Bond, Harlan Robins, Frank Bartel, Helge Taubert, Peter Wuerl, William Hait, Deborah Toppmeyer, Kenneth Offit, Arnold J. Levine
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5104–5110.
https://doi.org/10.1158/0008-5472.CAN-06-0180
Published: 16 May 2006
View articletitled, MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner
Open the PDF for MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner in another window
Journal Articles

A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect

Free
Gareth L. Bond, Wenwei Hu, Arnold Levine
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5481–5484.
https://doi.org/10.1158/0008-5472.CAN-05-0825
Published: 01 July 2005
View articletitled, A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect
Open the PDF for A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect in another window